Heme detoxification machinery (HDP)

The heme detoxification machinery in the Plasmodium digestive vacuole is a vital metabolic pathway that allows malaria parasites to survive while consuming host hemoglobin [1, 14]. During the intraerythrocytic stage of infection, the parasite degrades up to 80% of the host's hemoglobin to acquire essential amino acids, a process that releases large quantities of free heme (ferriprotoporphyrin IX) [14, 17]. Free heme is highly toxic to the parasite, as it can disrupt cell membranes and generate lethal reactive oxygen species [4, 14]. To mitigate this toxicity, the parasite utilizes a specialized machinery—comprising the Heme Detoxification Protein (HDP), lipids, and potentially histidine-rich proteins—to convert free heme into an insoluble, chemically inert crystalline polymer known as hemozoin or malaria pigment [3, 7, 14]. This biomineralization process is a validated therapeutic target and is the primary site of action for several major classes of antimalarial drugs, including quinolines like chloroquine and quinine [1, 4, 19]. These drugs typically bind to heme or the growing crystal surface, preventing further detoxification and leading to the accumulation of toxic heme-drug complexes that kill the parasite [1, 5, 14]. Because this pathway is unique to the parasite and absent in human physiology, it remains a cornerstone of antimalarial drug discovery and a key focus for overcoming emerging drug resistance [1, 15, 21].

Other names

Hemozoin formation pathwayHeme biocrystallization machineryMalaria pigment formationHeme detoxification protein complex

Inhibition of hemozoin biocrystallization and formation of toxic heme-drug complexes